Stay current with the latest sickle cell research, regulatory updates, and guidelines.
To evaluate the prevalence of psychosocial neglect and patterns of under-recognized psychosis among young adults with sickle cell disease (SCD) and to examine their impact on treatment, pain reduction, and...
To evaluate whether implementation of a standardized electronic medical record (EMR) admission order set could improve hospitalization outcomes for patients admitted with sickle cell pain crisis.
To investigate whether vaso-occlusive episodes (VOE) and other clinical factors influence variability in urine albumin-to-creatinine ratio (UACR) in patients with sickle cell disease (SCD).
To describe clinical presentation, diagnostic challenges, and management of fat embolism syndrome (FES) in adolescents with sickle cell disease (SCD).
To evaluate whether a biologicmarker — flow adhesion of whole blood to P-selectin (FA-WB-PSEL) — correlates with clinical outcomes inpatients with sickle cell disease treated with crizanlizumab.
To investigate whether alterations in resting-state functional connectivity are associated with pain sensitivity and cognitive changes in sickle cell disease (SCD).
To assess whether non-myeloablative hematopoietic cell transplantation can affect the progression of multi-organ damage in a preclinical sickle cell disease model.
To evaluate whether frequent home-based hemoglobin monitoring using nailbed optical measurement via a smartphone application could identify physiologic trends associated with the onset of vaso-occlusive crises in adults with sickle...
To evaluate whether palmitoylethanolamide (PEA), a non-intoxicating lipid mediator related to cannabinoid signaling, could reduce pain hypersensitivity and inflammatory activity in sickle cell disease (SCD).
To evaluate whether a structured Project ECHO virtual learning series could improve healthcare professionals’ knowledge and confidence in facilitating transition from pediatric to adult care for patients with sickle cell...